Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 158Lymphoma 156Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Lymphoma, Non-Hodgkin 120Leukemia 119Leukemia, Lymphocytic, Chronic, B-Cell 116Multiple Myeloma 115Lymphoma, Large B-Cell, Diffuse 100Leukemia, Myeloid, Acute 97Hodgkin Disease 82Myelodysplastic Syndromes 78Lymphoma, Follicular 74Lymphoma, Mantle-Cell 72Burkitt Lymphoma 66Lymphoma, B-Cell, Marginal Zone 52Melanoma 49Leukemia, Myelogenous, Chronic, BCR-ABL Positive 48Neoplasms 45Recurrence 38Hematologic Neoplasms 34Lymphoma, Large-Cell, Immunoblastic 33Myeloproliferative Disorders 31Congenital Abnormalities 31Waldenstrom Macroglobulinemia 30Neoplasms, Plasma Cell 30Leukemia, Myelomonocytic, Chronic 30Lymphoma, B-Cell 29Primary Myelofibrosis 27Lymphoma, Large-Cell, Anaplastic 27Leukemia, Myeloid, Accelerated Phase 26

Interventions

Mitomycin 2Hyperthermic Intraperitoneal Chemotherapy 2nintedanib 1nilotinib 1durvalumab 1Yoga 1Thalidomide 1Surgical Procedures, Operative 1Palonosetron 1Paclitaxel 1Oxaliplatin 1Laparoscopy 1Fentanyl 1Electrocardiography 1Cytoreduction Surgical Procedures 1Cyclophosphamide 1Cryotherapy 1Algorithms 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Appendiceal Neoplasms × Cyclophosphamide × Clear all
NCT02963831 2022-12-22

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

Ludwig Institute for Cancer Research

Phase 1/2 Completed
67 enrolled 16 charts
GastrointestinalGynecologic

Appendiceal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡